Global "Pain
management devices Market" 2022 Industry
research report covers the industry overview with Marketplace Size, Share,
Development, futuristic cost, earnings, demand and distribution data. Its vast
repository offers an analytical summary of the marketplace that can help to the
new and existing player to take a significant decision.
In this report, we
thoroughly examine and analyse the Global market for Pain management devices so
that market participants can improve their business strategy and ensure
long-term success. This report provides players with useful information and
suggests result-based ideas to give them a competitive advantage in the global Pain
management devices industry. It will show how other players compete in the
global Pain management devices Market and explain the strategies you use to
differentiate yourself from other participants.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/pain-management-devices-market/request-sample
Industry Insights
The pain management devices
market was estimated to be USD 3.18 billion globally in 2014. This can be
attributed to increasing geriatric population along with rising number of
population suffering from diabetes. According to estimates published by International
Diabetes Federation, the prevalence of diabetes is predicted to increase to
552.0 million by 2030 from 355.0 million in 2011 globally.
The increasing incidence of
diabetes makes a huge population base susceptible towards development of
chronic pain which is expected to drive the growth. The market is primarily
driven by aging population base which is more prone to develop various chronic
disorders. These chronic disorders include diabetes, cancer and cardiovascular
disorders accounting for over 87.0% of disease burden in geriatric population.
In addition, there has been
an increasing prevalence of cancer accompanied with chronic pain and serves as
a potential contributor towards high potential growth. The trauma is a result
of compression of a nerve by tumor and other factors which can be subsided with
the use of these devices. According to estimates, over 20.0 to 50.0% of
patients suffer from acute pain during diagnosis and about 75.0% as the disease
progresses.
Application Insights
The major applications
include trauma, musculoskeletal disorders, migraine and facial, neuropathic and
cancer, which can be accessed through neurostimulation products. A substantial
share was held by neurostimulation devices owing to the efficient results
achieved by stimulation of spinal cord. Additionally, these products also have
various benefits such as stimulation of customized level based on the
activities done by the individual in a day. These show their action by inducing
cell necrosis by temperature thermal therapy.
Regional Insights
The market was dominated by
North America with a revenue share of around 49.5% in 2014. The dominance can
be as a consequence of supportive healthcare infrastructure which helps in
increasing accessibility of pain management devices. Moreover, initiatives by
government such as Affordable Care Act and Precision Medicine along with
favorable reimbursement policies contribute to the regional growth. Also,
increasing awareness level amongst individuals coupled with high healthcare
expenditure is predicted to broaden the growth potential.
A lucrative growth is
expected to be witnessed by Asia Pacific throughout the forecast period as a
consequence of supportive governmental policies for improvement in healthcare
infrastructure. Also, emerging economies such as China and India have high
disposable incomes and is anticipated to drive the demand.
Competitive Insights
Prominent players include
Stryker Corporation, St. Jude Medical, Smiths Medical, Medtronic Plc, Pfizer,
DJO Global LLC, Codman and Shurtleff, Boston Scientific Corporation, Baxter
International Inc., Melsungen AG., and B Braun. Key strategies include
acquisitions, mergers and alliances to provide a competitive edge.
For instance, Spinal
Modulation Inc., developer of axium neurotransmitter system, which helps in
targeting neural structure in spine, was acquired by St. Jude Medical in May
2015 which is predicted to strengthen product portfolio of the company.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment